_________
false
קומפיוגן בע"מ
2
381
COMPUGEN LTD
Corporation no:
511779639
15525
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
17/12/2025
www.isa.gov.il
www.tase.co.il
Reference:
2025-02-100734
Time of broadcast:
13:43
13:43
The corporation scheduled the publication of the report to
17/12/2025 14:05
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
6K: קומפיוג'ן עושה מוניטיזציה של חלק מתמלוגים עתידיים של Rilvegostomig מ-AstraZeneca תמורת סך של עד 90 מיליון דולר
Compugen_6K_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
TASE
Date of revision of form structure:
06/08/2024
Address:
Harokmim
26
,
Holon
5885849
,
Tel:
03-7658585
,
03-7658525
Fax:
03-7658555
E-mail address:
eranbd@cgen.com
Previous names of reporting entity:
Name of the Signatory:
Silberman David
Position of Signatory in the reporting corporation:
Chief Financial Officer
Name of Employer Company:
Address:
Harokmim St.
26
,
Holon
5885849
Telephone:
03-7658585
Facsimile:
03-7658555
E-mail:
davids@cgen.com
1